19594 Federal Register / Vol. 74, No. 81 / Wednesday, April 29, 2009 / Notices 

presentations should attend a 

prehearing conference to be held at 9:30 

a.m. on May 28, 2009 at the U.S. 

International Trade Commission 

Building. Oral testimony and written 

materials to be submitted at the hearing 

are governed by sections 201.6(b)(2) and 

201.13(f) of the Commission’s rules. 

Written submissions.—Each party is 

encouraged to submit a prehearing brief 

to the Commission. The deadline for 

filing prehearing briefs is May 28, 2009. 

Parties may also file posthearing briefs. 

The deadline for filing posthearing 

briefs is June 8, 2009. In addition, any 

person who has not entered an 

appearance as a party to the 

investigation may submit a written 

statement of information pertinent to 

the consideration of market disruption 

or threat thereof and/or remedy on or 

before June 8, 2009. Parties may submit 

final comments on market disruption on 

or before June 16, 2009 and on remedy 

on or before June 24, 2009. Final 

comments shall contain no more than 

ten (10) double-spaced and single-sided 

pages of textual material. All written 

submissions must conform with the 

provisions of section 201.8 of the 

Commission’s rules; any submissions 

that contain confidential business 

information must also conform with the 

requirements of section 201.6 of the 

Commission’s rules. The Commission’s 

rules authorize filing submissions with 

the Secretary by facsimile or electronic 

means only to the extent permitted by 

section 201.8 of the rules (see Handbook 

for Electronic Filing Procedures, http:// 

www.usitc.gov/secretary/ 

fed_reg_notices/rules/documents/ 

handbook_on_electronic_filing.pdf). 

Persons with questions regarding 

electronic filing should contact the 

Secretary (202–205–2000). 

In accordance with section 201.16(c) 

of the Commission’s rules, each 

document filed by a party to the 

investigation must be served on all other 

parties to the investigation (as identified 

by the service list), and a certificate of 

service must be timely filed. The 

Secretary will not accept a document for 

filing without a certificate of service. 

Remedy.—No separate hearing on the 

issue of remedy will be held. Those 

parties wishing to present arguments on 

the issue of remedy may do so orally at 

the hearing or in their prehearing or 

posthearing briefs or other written 

submissions. 

Authority: This investigation is being 

conducted under the authority of section 421 

of the Trade Act of 1974; this notice is 

published pursuant to section 206.3 of the 

Commission’s rules. 

By order of the Commission. 

Marilyn R. Abbott, 

Secretary to the Commission. 

Issued: April 24, 2009. 

William R. Bishop, 

Acting Secretary to the Commission. 

[FR Doc. E9–9760 Filed 4–28–09; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Importer of Controlled Substances; 

Notice of Application 

This is notice that on March 10, 2009, 

Penick Corporation, 33 Industrial Park 

Road, Pennsville, New Jersey 08070, 

made application by renewal to the 

Drug Enforcement Administration 

(DEA) for registration as an importer of 

the basic classes of controlled 

substances listed in schedule II. 

Drug Schedule 

Coca Leaves (9040) ..................... II 

Raw Opium (9600) ....................... II 

Poppy Straw (9650) ...................... II 

Concentrate of Poppy Straw 

(9670) ........................................ II 

The company plans to import the 

listed controlled substances to 

manufacture bulk controlled substance 

intermediates for sale to its customers. 

As noted in a previous notice 

published in the Federal Register on 

September 23, 1975 (40 FR 43745), all 

applicants for registration to import a 

basic class of any controlled substances 

in schedule I or II are, and will continue 

to be, required to demonstrate to the 

Deputy Assistant Administrator, Office 

of Diversion Control, Drug Enforcement 

Administration, that the requirements 

for such registration pursuant to 21 

U.S.C. 958(a); 21 U.S.C. 823(a); and 21 

CFR 1301.34(b), (c), (d), (e), and (f) are 

satisfied. 

Dated: April 17, 2009. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. E9–9778 Filed 4–28–09; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Importer of Controlled Substances; 

Notice of Application 

Pursuant to 21 U.S.C. 958(i), the 

Attorney General shall, prior to issuing 

a registration under this Section to a 

bulk manufacturer of a controlled 

substance in schedule I or II, and prior 

to issuing a regulation under 21 U.S.C. 

952(a)(2) authorizing the importation of 

such a substance, provide 

manufacturers holding registrations for 

the bulk manufacture of the substance 

an opportunity for a hearing. 

Therefore, in accordance with Title 21 

Code of Federal Regulations 

§ 1301.34(a), this is notice that on 

February 20, 2009, Meridian Medical 

Technologies, 2555 Hermelin Drive, St. 

Louis, Missouri 63144, made 

application by renewal to the Drug 

Enforcement Administration (DEA) to 

be registered as an importer of 

Morphine (9300), a basic class of 

controlled substance listed in schedule 

II. 

The company plans to import 

products for research experimentation 

or clinical use and analytical testing. 

Any bulk manufacturer who is 

presently, or is applying to be, 

registered with DEA to manufacture 

such basic class of controlled substance 

may file comments or objections to the 

issuance of the proposed registration 

and may, at the same time, file a written 

request for a hearing on such 

application pursuant to 21 CFR 1301.43 

and in such form as prescribed by 21 

CFR 1316.47. 

Any such comments or objections 

being sent via regular mail should be 

addressed, in quintuplicate, to the Drug 

Enforcement Administration, Office of 

Diversion Control, Federal Register 

Representative (ODL), 8701 Morrissette 

Drive, Springfield, Virginia 22152; and 

must be filed no later than May 29, 

2009. 

This procedure is to be conducted 

simultaneously with, and independent 

of, the procedures described in 21 CFR 

1301.34(b), (c), (d), (e), and (f). As noted 

in a previous notice published in the 

Federal Register on September 23, 1975 

(40 FR 43745–46), all applicants for 

registration to import a basic class of 

any controlled substance listed in 

schedule I or II are, and will continue 

to be, required to demonstrate to the 

Deputy Assistant Administrator, Office 

of Diversion Control, Drug Enforcement 

Administration, that the requirements 

for such registration pursuant to 21 

U.S.C. 958(a), 21 USC § 823(a), and 21 

CFR 1301.34(b), (c), (d), (e), and (f) are 

satisfied. 


pwalker on PROD1PC71 with NOTICES